Skip to main content

Table 3 GenScript cPass SARS-CoV-2 sVNT test positivity according to the vaccination schedule

From: Kinetics of adaptive immune responses after administering mRNA-Based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections

cPass sVNT

  

Uninfected population

 

Infected population

 

Baseline

1st dose

2nd dose

Baseline

1st dose

2nd dose

 

N (%)

N (%)

N (%)

N (%)

N (%)

N (%)

Negative

 

23 (100.0)

1 (4.3)

0 (0.0)

10 (32.2)

0 (0.0)

0 (0.0)

Positive

 

0 (0.0)

22 (95.7)

23 (100.0)

21 (67.7)

26 (100.0)

21 (100.0)